Sylvain Orenga
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Bacterial biofilms and quorum sensing 4
-
- Antifungal resistance and susceptibility 5
- Co-authors
- John D. Perry (25 shared papers)Rosaleen J. Anderson (8 shared papers)Paul W. Groundwater (7 shared papers)Linda Váradi (3 shared papers)David Pincus (2 shared papers)David E. Hibbs (2 shared papers)Jia Lin Luo (1 shared paper)Sonia Chatellier (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Bioorganic & Medicinal Chemistry (4 papers)Journal of Clinical Microbiology (3 papers)Frontiers in Microbiology (2 papers)Organic & Biomolecular Chemistry (2 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Sylvain Orenga
38 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Medicine 241
- Clinical Biochemistry 216
- Endocrinology 150
- Applied Microbiology and Biotechnology 53
- Infectious Diseases 259
Countries citing papers authored by Sylvain Orenga
This map shows the geographic impact of Sylvain Orenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Orenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Orenga more than expected).
Fields of papers citing papers by Sylvain Orenga
This network shows the impact of papers produced by Sylvain Orenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Orenga. The network helps show where Sylvain Orenga may publish in the future.
Co-authors
The 25 scholars most cited alongside Sylvain Orenga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Methods for the detection and identification of pathogenic bacteria: past, present, and future Hit paper breakdown → | 2017 | 408 |
| 2 | 2011 | 150 | |
| 3 | 2007 | 130 | |
| 4 | 2018 | 95 | |
| 5 | 2009 | 93 | |
| 6 | 2013 | 54 | |
| 7 | 2011 | 53 | |
| 8 | 2016 | 39 | |
| 9 | 2010 | 39 | |
| 10 | 2013 | 34 | |
| 11 | 2008 | 31 | |
| 12 | 2001 | 29 | |
| 13 | 2021 | 27 | |
| 14 | 1991 | 27 | |
| 15 | 2017 | 25 | |
| 16 | 2008 | 22 | |
| 17 | 2022 | 21 | |
| 18 | 2012 | 20 | |
| 19 | 2021 | 17 | |
| 20 | 2007 | 16 |
About Sylvain Orenga
Sylvain Orenga is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Microbiology and Oncology, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (7 papers), Bacterial Identification and Susceptibility Testing (7 papers), Antibiotic Resistance in Bacteria (6 papers), Antifungal resistance and susceptibility (5 papers), Antimicrobial Peptides and Activities (5 papers), Bacterial biofilms and quorum sensing (4 papers), Cystic Fibrosis Research Advances (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Molecular Medicine (241 citations), Clinical Biochemistry (216 citations), Endocrinology (150 citations), Applied Microbiology and Biotechnology (53 citations) and Infectious Diseases (259 citations). Sylvain Orenga has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include John D. Perry, Rosaleen J. Anderson, Paul W. Groundwater, Linda Váradi, David Pincus, David E. Hibbs, Jia Lin Luo, Sonia Chatellier, Arthur L. James and Claire Mercier. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry, Journal of Clinical Microbiology, Frontiers in Microbiology and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.